Colgate Palmolive Co (CL) shareholders
CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3026% above fair value
$99.67+1.77 (+1.81%)
Close on Nov 13, 2026Market cap $79.23BP/E 39.1Yield 2.09%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
85.6%
681M of 795M shares
Institutional holders
2,013
191 new, 102 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
0 buys · 20 sales
Net sold $64.22M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 65,563,643 | 8.00% | 13G (passive) amendment | Sep 30, 2024 |
| Vanguard Capital Management | 60,404,276 | 7.52% | 13G (passive) | Mar 31, 2026 |
| State Street Corporation | – | 5.79% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CL | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 69,915,472 | 8.80% | $6.41B | −2,727,530 | 0.10% |
| Vanguard Capital Management LLC | 52,246,333 | 6.57% | $4.79B | +26,509 | 0.10% |
| State Street Corp | 47,020,966 | 5.92% | $4.31B | −698,516 | 0.13% |
| Price T Rowe Associates Inc /Md/ | 27,909,525 | 3.51% | $2.56B | −5,819,640 | 0.26% |
| Vanguard Portfolio Management LLC | 24,021,137 | 3.02% | $2.20B | +198,391 | 0.10% |
| Geode Capital Management, LLC | 23,144,319 | 2.91% | $2.14B | +244,029 | 0.11% |
| Morgan Stanley | 22,072,925 | 2.78% | $2.02B | +1,191,571 | 0.11% |
| First Eagle Investment Management, LLC | 16,411,398 | 2.06% | $1.50B | +8,294,616 | 1.25% |
| Bank of New York Mellon Corp | 13,532,417 | 1.70% | $1.24B | +1,010,872 | 0.20% |
| Deutsche Bank AG\ | 11,751,973 | 1.48% | $1.08B | −176,188 | 0.31% |
| Norges Bank | 9,686,029 | 1.22% | $888.02M | New | 0.09% |
| Acadian Asset Management LLC | 9,096,779 | 1.14% | $833.94M | +1,159,376 | 0.99% |
| FMR LLC | 8,983,071 | 1.13% | $823.57M | −25,914 | 0.04% |
| Goldman Sachs Group Inc | 8,571,015 | 1.08% | $785.79M | −904,819 | 0.07% |
| Northern Trust Corp | 8,471,575 | 1.07% | $776.67M | −209,188 | 0.09% |
| Invesco Ltd. | 8,325,612 | 1.05% | $763.29M | −13,381 | 0.06% |
| State Farm Mutual Automobile Insurance Co | 6,730,570 | 0.85% | $617.06M | – | 0.42% |
| UBS Asset Management Americas Inc | 6,471,404 | 0.81% | $593.30M | −357,560 | 0.11% |
| Amundi | 6,218,257 | 0.78% | $570.09M | +1,033,918 | 0.14% |
| Bank Of America Corp /De/ | 6,189,824 | 0.78% | $567.48M | −447,773 | 0.04% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,013 | 681M | 85.6% | 191 / 729 | 725 / 102 | 52M | 47M |
| Q1 2026 | 1,961 | 676M | 85.0% | 203 / 714 | 705 / 107 | 155M | 68M |
| Q4 2025 | 1,891 | 675M | 84.9% | 217 / 594 | 762 / 131 | 67M | 62M |
| Q3 2025 | 1,846 | 673M | 84.6% | 143 / 585 | 752 / 184 | 46M | 55M |
| Q2 2025 | 1,916 | 682M | 85.8% | 120 / 643 | 763 / 122 | 51M | 46M |
| Q1 2025 | 1,946 | 680M | 85.5% | 158 / 653 | 784 / 115 | 44M | 45M |
| Q4 2024 | 1,934 | 687M | 86.4% | 223 / 639 | 712 / 166 | 60M | 48M |
| Q3 2024 | 1,912 | 677M | 85.2% | 186 / 667 | 690 / 74 | 104M | 38M |
| Q2 2024 | 1,821 | 674M | 84.7% | 159 / 621 | 668 / 79 | 45M | 89M |
| Q1 2024 | 1,765 | 720M | 90.6% | 156 / 564 | 716 / 108 | 68M | 40M |
| Q4 2023 | 1,741 | 694M | 87.3% | 230 / 560 | 642 / 87 | 69M | 42M |
| Q3 2023 | 1,621 | 667M | 83.9% | 101 / 506 | 667 / 140 | 48M | 42M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
967 funds held CL in Q2 2026, 55% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CL | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 25,400,466 | 3.20% | $2.33B | 0.10% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 20,732,788 | 2.61% | $1.90B | 0.11% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 11,006,699 | 1.38% | $1.01B | 0.11% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 10,315,187 | 1.30% | $929.71M | 0.11% | May 31, 2026 |
| Vanguard Value Index Fund | 7,610,832 | 0.96% | $697.76M | 0.27% | Jun 30, 2026 |
| State Street(R) Consumer Staples Select Sector SPDR(R) ETF | 6,992,901 | 0.88% | $641.11M | 4.70% | Jun 30, 2026 |
| First Eagle Global Fund | 5,342,322 | 0.67% | $487.75M | 0.64% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 4,527,448 | 0.57% | $413.36M | 0.32% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 4,344,032 | 0.55% | $398.26M | 0.11% | Jun 30, 2026 |
| Vanguard High Dividend Yield Index Fund | 3,202,168 | 0.40% | $292.36M | 0.29% | Jul 31, 2026 |
| BNY Mellon Dynamic Value Fund | 3,084,795 | 0.39% | $278.03M | 2.29% | May 31, 2026 |
| T. Rowe Price Equity Income Fund | 2,877,000 | 0.36% | $263.76M | 1.49% | Jun 30, 2026 |
| T. Rowe Price Dividend Growth Fund, Inc. | 2,810,581 | 0.35% | $257.67M | 1.09% | Jun 30, 2026 |
| Fidelity SAI U.S. Quality Index Fund | 2,792,485 | 0.35% | $254.95M | 0.71% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Dividend ETF | 2,703,667 | 0.34% | $247.87M | 1.16% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Noel R. Wallace | Chairman, President & CEO, Director | 467,208 | 0.06% | Nov 6, 2026 |
| Gregory Malcolm | EVP and Controller | 18,761 | 0.00% | Nov 12, 2026 |
| Panagiotis Tsourapas | COO, CD, EMEA, APac, Skin | 80,993 | 0.01% | Nov 6, 2026 |
| John Hazlin | Chief Growth Officer | 32,565 | 0.00% | Nov 6, 2026 |
| Betsy Fishbone | CLO and Secretary | 24,436 | 0.00% | Sep 18, 2026 |
| Sally Massey | Chief People Officer | 23,596 | 0.00% | Sep 18, 2026 |
| Shane Grant | COO, Americas | 79,503 | 0.01% | Sep 18, 2026 |
| Stanley J. Sutula Iii | Chief Financial Officer | 79,360 | 0.01% | Sep 18, 2026 |
| Jennifer Daniels | CLO and Secretary | 91,681 | 0.01% | Feb 25, 2026 |
| Prabha Parameswaran | Vice Chair | 63,783 | 0.01% | Sep 16, 2025 |
| Lorrie M. Norrington | Director | 43,383 | 0.01% | Nov 9, 2026 |
| Brian Newman | Director | 8,094 | 0.00% | Oct 2, 2026 |
| John P. Bilbrey | Director | 45,444 | 0.01% | Oct 2, 2026 |
| John T. Cahill | Director | 64,730 | 0.01% | Aug 7, 2026 |
| Lisa Edwards | Director | 18,182 | 0.00% | May 13, 2026 |
| Martina Hundmejean | Director | 16,206 | 0.00% | May 13, 2026 |
| C. Martin Harris | Director | 24,517 | 0.00% | May 13, 2026 |
| Kimberly A. Nelson | Director | 14,223 | 0.00% | May 13, 2026 |
| Christopher S. Boerner | Director | 1,383 | 0.00% | May 13, 2026 |
| Steven A. Cahillane | Director | 6,754 | 0.00% | May 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Gregory Malcolm EVP and Controller | Nov 10, 2026 | Sale | −4,100 | $97.97 | $401.68K | 10,061 |
| Lorrie M. Norrington Director | Nov 5, 2026 | Sale | −4,170 | $99.31 | $414.12K | 43,383 |
| Lorrie M. Norrington Director | Nov 5, 2026 | Option exercise | +4,170 | $71.56 | $298.41K | 47,553 |
| Noel R. Wallace Chairman, President & CEO, Director | Nov 5, 2026 | Sale | −20,000 | $100.26 | $2.01M | 359,700 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Nov 4, 2026 | Sale | −19,938 | $98.74 | $1.97M | 9,111 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Nov 4, 2026 | Option exercise | +19,938 | $76.41 | $1.52M | 29,049 |
| John Hazlin Chief Growth Officer | Nov 4, 2026 | Sale | −23,376 | $99.15 | $2.32M | 27,021 |
| John Hazlin Chief Growth Officer | Nov 4, 2026 | Option exercise | +23,376 | $77.04 | $1.80M | 50,397 |
| Lorrie M. Norrington Director | Oct 1, 2026 | Award | +300 | $87.42 | $26.23K | 43,310 |
| Brian Newman Director | Oct 1, 2026 | Award | +214 | $87.42 | $18.71K | 8,058 |
| John P. Bilbrey Director | Oct 1, 2026 | Award | +271 | $87.42 | $23.69K | 40,725 |
| Noel R. Wallace Chairman, President & CEO, Director | Sep 16, 2026 | Award | +29,649 | – | – | 379,700 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sep 16, 2026 | Award | +4,597 | – | – | 11,447 |
| Shane Grant COO, Americas | Sep 16, 2026 | Award | +7,355 | – | – | 79,503 |
| John Hazlin Chief Growth Officer | Sep 16, 2026 | Award | +3,908 | – | – | 27,021 |
| Gregory Malcolm EVP and Controller | Sep 16, 2026 | Award | +1,081 | – | – | 14,162 |
| Betsy Fishbone CLO and Secretary | Sep 16, 2026 | Award | +2,207 | – | – | 16,050 |
| Stanley J. Sutula Iii Chief Financial Officer | Sep 16, 2026 | Award | +8,045 | – | – | 79,029 |
| Sally Massey Chief People Officer | Sep 16, 2026 | Award | +3,333 | – | – | 15,397 |
| John Hazlin Chief Growth Officer | Sep 13, 2026 | Tax withholding | −499 | $86.80 | $43.31K | 23,113 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sep 13, 2026 | Tax withholding | −922 | $86.80 | $80.03K | 6,850 |
| Betsy Fishbone CLO and Secretary | Sep 13, 2026 | Tax withholding | −472 | $86.80 | $40.97K | 13,843 |
| Noel R. Wallace Chairman, President & CEO, Director | Sep 13, 2026 | Tax withholding | −4,892 | $86.80 | $424.63K | 350,051 |
| Sally Massey Chief People Officer | Sep 13, 2026 | Tax withholding | −686 | $86.80 | $59.54K | 12,064 |
| Stanley J. Sutula Iii Chief Financial Officer | Sep 13, 2026 | Tax withholding | −1,385 | $86.80 | $120.22K | 70,984 |
| Gregory Malcolm EVP and Controller | Sep 13, 2026 | Tax withholding | −225 | $86.80 | $19.53K | 13,081 |
| John Hazlin Chief Growth Officer | Sep 12, 2026 | Tax withholding | −439 | $86.80 | $38.11K | 23,612 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sep 12, 2026 | Tax withholding | −618 | $86.80 | $53.64K | 7,772 |
| Betsy Fishbone CLO and Secretary | Sep 12, 2026 | Tax withholding | −331 | $86.80 | $28.73K | 14,315 |
| Noel R. Wallace Chairman, President & CEO, Director | Sep 12, 2026 | Tax withholding | −3,516 | $86.80 | $305.19K | 354,943 |
| Sally Massey Chief People Officer | Sep 12, 2026 | Tax withholding | −459 | $86.80 | $39.84K | 12,750 |
| Stanley J. Sutula Iii Chief Financial Officer | Sep 12, 2026 | Tax withholding | −927 | $86.80 | $80.46K | 72,369 |
| Gregory Malcolm EVP and Controller | Sep 12, 2026 | Tax withholding | −151 | $86.80 | $13.11K | 13,306 |
| John Hazlin Chief Growth Officer | Sep 11, 2026 | Tax withholding | −649 | $86.80 | $56.33K | 24,051 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sep 11, 2026 | Tax withholding | −684 | $86.80 | $59.37K | 8,390 |
| Betsy Fishbone CLO and Secretary | Sep 11, 2026 | Tax withholding | −404 | $86.80 | $35.07K | 14,646 |
| Noel R. Wallace Chairman, President & CEO, Director | Sep 11, 2026 | Tax withholding | −4,071 | $86.80 | $353.36K | 358,459 |
| Sally Massey Chief People Officer | Sep 11, 2026 | Tax withholding | −651 | $86.80 | $56.51K | 13,209 |
| Stanley J. Sutula Iii Chief Financial Officer | Sep 11, 2026 | Tax withholding | −1,197 | $86.80 | $103.90K | 73,296 |
| Shane Grant COO, Americas | Sep 11, 2026 | Tax withholding | −622 | $86.80 | $53.99K | 72,148 |
| Gregory Malcolm EVP and Controller | Sep 11, 2026 | Tax withholding | −167 | $86.80 | $14.50K | 13,457 |
| Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Aug 24, 2026 | Sale | −10,000 | $92.05 | $920.50K | 64,901 |
| John T. Cahill Director | Aug 6, 2026 | Sale | −4,170 | $93.37 | $389.35K | 28,373 |
| John T. Cahill Director | Aug 6, 2026 | Option exercise | +4,170 | $71.56 | $298.41K | 32,543 |
| Noel R. Wallace Chairman, President & CEO, Director | Aug 5, 2026 | Sale | −161,021 | $92.52 | $14.90M | 362,231 |
| Noel R. Wallace Chairman, President & CEO, Director | Aug 5, 2026 | Option exercise | +161,021 | $72.29 | $11.64M | 523,252 |
| Noel R. Wallace Chairman, President & CEO, Director | Aug 4, 2026 | Sale | −161,021 | $91.92 | $14.80M | 362,231 |
| Noel R. Wallace Chairman, President & CEO, Director | Aug 4, 2026 | Option exercise | +161,021 | $72.29 | $11.64M | 523,252 |
| John P. Bilbrey Director | Jul 1, 2026 | Award | +265 | $89.45 | $23.70K | 40,229 |
| Brian Newman Director | Jul 1, 2026 | Award | +209 | $89.45 | $18.70K | 7,831 |
| Lorrie M. Norrington Director | Jul 1, 2026 | Award | +293 | $89.45 | $26.21K | 42,769 |
| Shane Grant COO, Americas | Jun 16, 2026 | Tax withholding | −23,347 | $90.66 | $2.12M | 72,481 |
| Gregory Malcolm EVP and Controller | May 15, 2026 | Sale | −2,300 | $88.44 | $203.41K | 13,598 |
| Brian Newman Director | May 11, 2026 | Award | +2,075 | – | – | 7,621 |
| Kimberly A. Nelson Director | May 11, 2026 | Award | +2,075 | – | – | 11,634 |
| Martina Hundmejean Director | May 11, 2026 | Award | +2,075 | – | – | 16,206 |
| Lorrie M. Norrington Director | May 11, 2026 | Award | +2,075 | – | – | 42,312 |
| C. Martin Harris Director | May 11, 2026 | Award | +1,556 | – | – | 24,517 |
| John P. Bilbrey Director | May 11, 2026 | Award | +2,075 | – | – | 39,820 |
| Lisa Edwards Director | May 11, 2026 | Award | +2,075 | – | – | 18,182 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
2.34%
19M shares short
Days to cover
3.8
At 5M shares a day
Change since last report
+6.5%
From 17M shares
Short volume, 20 days
53.5%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Colgate Palmolive's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,193 shares on Oct 2, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lorrie M. Norrington Officer | Nov 5, 2026 | 4,170 | $414.12K | Nov 5, 2026 | Exercise of employee stock options |
| Noel R. Wallace Officer | Nov 5, 2026 | 20,000 | $2.01M | Nov 5, 2026 | Vesting of restricted stock unit awards |
| John Hazlin Officer | Nov 4, 2026 | 23,376 | $2.32M | Nov 4, 2026 | Exercise of employee stock options |
| Panagiotis Tsourapas Officer | Nov 4, 2026 | 19,938 | $1.97M | Nov 4, 2026 | Exercise of employee stock options |
| Panagiotis Tsourapas Officer | Aug 24, 2026 | 10,000 | $920.48K | Aug 24, 2026 | Vesting of restricted stock unit awards |
| John T. Cahill Director | Aug 6, 2026 | 4,170 | $389.36K | Aug 6, 2026 | Exercise of employee stock options |
| Noel R. Wallace Officer | Aug 5, 2026 | 161,021 | $14.90M | Aug 5, 2026 | Exercise of employee stock options |
| Steven A. Cahillane Officer | Aug 4, 2026 | 1,762 | $159.58K | Aug 4, 2026 | Exercise of employee stock options |
| Noel R. Wallace Officer | Aug 4, 2026 | 161,021 | $14.80M | Aug 4, 2026 | Exercise of employee stock options |
| Panagiotis Tsourapas Officer | Feb 12, 2026 | 15,000 | $1.47M | Feb 12, 2026 | Exercise of employee stock options |
| Panagiotis Tsourapas Officer | Feb 11, 2026 | 35,000 | $3.31M | Feb 11, 2026 | Exercise of employee stock options |
| John Hazlin Officer | Feb 10, 2026 | 20,989 | $1.98M | Feb 10, 2026 | Exercise of employee stock options |
| Jennifer Daniels Officer | Feb 4, 2026 | 22,000 | $2.08M | Feb 4, 2026 | Exercise of employee stock options |
| Noel R. Wallace Officer, Director | Feb 4, 2026 | 45,568 | $4.28M | Feb 4, 2026 | Vesting of performance share unit award |
| Stanley J. Sutula Iii Officer | Feb 4, 2026 | 97,843 | $9.22M | Feb 4, 2026 | Exercise of employee stock options |
See a number that looks wrong?